Injectable Drug Delivery Resources

  1. Is It Ever Too Soon To Start Your Performance Testing Assessment?

    Developing a safe and effective injectable combination product involves performing risk assessments, establishing a set of Critical Quality Attributes (CQAs), and performing design verification testing.

  2. Improved Biomanufacturing Processes And Drug Product Stability 9/20/2022

    Improve upstream media for bioavailability and foam stability, downstream buffers for purification, and the formulation and final fill drug product stability with this highly interdisciplinary process.

  3. Successful Industrialization Requires Solid Foundations

    Learn how choosing the appropriate quality of containment systems from the outset is critical to the successful industrialisation of an injectable drug product and review some of the associated challenges.

  4. A Risk Management Approach For The Pharmaceutical Industry 10/14/2026

    Replacing fluorinated chemistries across pharma isn’t simple. Growing pressures make it critical to prioritize risks and take a sequenced, evidence-based approach to mitigation.

  5. Characterizing Injection Factors And Their Impact On System Function 2/9/2022

    The transition of intravenous in-clinic chronic disease therapies to large volume subcutaneous injections in alternate settings has created an evolving roster of new formulations and treatment options.

  6. Where Expertise Lives: Inside The Decisions That Define Sterile Fill Finish Excellence 9/25/2026

    From contamination control to regulatory compliance, sterile fill finish requires coordinated planning. Discover strategies for a reliable path to commercial supply.

  7. Expanding Subcutaneous Design Brick By Brick 8/14/2026

    Biologics are growing more complex. But what if the syringe itself could unlock new possibilities? Discover the technology “bricks” quietly reshaping subcutaneous drug delivery.

  8. How Recent Trends Impact Bringing Your Molecule To Market 7/9/2024

    With accelerated approval times, growing competition between drugs, and a shift from hospital to home care, you’re under pressure to develop a delivery device in parallel with your drug.

  9. What Downstream Deviations Reveal About Upstream Process Maturity 9/17/2026

    Fill finish deviations can reveal upstream process issues early. Identifying these signals helps reduce variability, improve process control, and strengthen sterile injectable manufacturing.

  10. Closing The Care Gap: Clinician Assistive Technologies 9/1/2025

    This technology addresses workforce shortages and growing medical complexity by helping healthcare providers manage rising demands, improve efficiency, reduce errors, and extend care access.